Glycemic Effects of Honey

Status Completed

Clinical Trial Summary

Honey has been used as a sweetener for centuries. Recent data indicate that honey consumption may have beneficial effects upon glucose intolerance, a health issue currently affecting 57 million Americans of every age and ethnicity. In order to evaluate the glycemic effect of honey, the investigators will carry out a human trial assessing biomarkers of blood glucose responses, insulin sensitivity, oxidative stress, and inflammatory markers. Our primary objective is to determine the glycemic effects of honey in comparison to sucrose and high fructose corn syrup (HFCS). The investigators hypothesize that honey will promote improved glucose tolerance and insulin sensitivity compared to both sucrose and high fructose corn syrup in normal glycemic and glucose intolerant adults.

Clinical Trial Description

Glucose intolerance and insulin resistance are associated with the development of the metabolic syndrome and chronic diseases, including, hyperlipidemia, hypertension, obesity, and type II diabetes. Current National Institutes of Health statistics estimate that 1 in 6 Americans have insulin resistance (www.diabetes.niddk.nih.gov/dm/pubs/statistics). Insulin resistance in humans is associated with glucose intolerance, enhanced oxidative stress, inflammation and alterations in lipid profiles. Improvements in glucose tolerance are associated with improved insulin sensitivity resulting in improved inflammatory and oxidative status. Dietary modification to reduced day-long serum insulin concentration is postulated to decrease hepatic cholesterol production through inhibition of HMG CoA reductase, the rate limiting enzyme involved in cholesterol synthesis.

Maintenance of normal blood glucose is dependent on the body's ability to modulate insulin secretion in response to the glucose load consumed. Although diet may be an important factor in glucose tolerance, the role of nutritive sweeteners has not been clearly defined. Much research has been performed on the effect of dietary sugars on chronic disease risk factors, including animal studies, and human studies ranging from epidemiologic to controlled feeding trials with most of this work focused on the monosaccharides: fructose and glucose or the disaccharide, sucrose.

Little work has been done on the comparative effects of honey and other nutritive sweeteners in relation to glucose tolerance and insulin sensitivity. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01371266
Study type	Interventional
Source	USDA Grand Forks Human Nutrition Research Center
Contact
Status	Completed
Phase	N/A
Start date	June 2011
Completion date	August 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04082585` - Total Health Improvement Program Research Project
Enrolling by invitation	`NCT05367024` - Broccoli Effect on Glycated Haemoglobin (HbA1c)	N/A
Withdrawn	`NCT02400450` - Designer Functional Foods on Parameters of Metabolic and Vascular in Prediabetes	N/A
Completed	`NCT02933424` - Project Plant Protein: the P3 Study in Humans	N/A
Completed	`NCT02656212` - Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin (Part 2)	Phase 1
Completed	`NCT02330276` - Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin	Phase 1
Completed	`NCT01488279` - Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid Therapy	N/A
Completed	`NCT00831129` - A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs	Phase 2/Phase 3
Completed	`NCT00536250` - Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth	N/A
Recruiting	`NCT05563090` - Investigating the Syndrome Differentiation of Diabetic and Pre-diabetic Using Digitalized TCM Diagnostic Tools
Active, not recruiting	`NCT04991142` - Models of Nutrition From Continuous Glucose Monitors
Completed	`NCT02759055` - Pre-Diabetes Cardiovascular (CV) Care (Pre-Diabetes Wizard)	N/A
Completed	`NCT00775684` - Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass	N/A
Completed	`NCT03695913` - Continuous Glucose Monitoring (CGM) With a Low Carbohydrate Diet to Reduce Weight in Patients With Pre-Diabetes	N/A
Completed	`NCT04051008` - CTSI Pilot: Improving Adherence to Diabetic Diet	N/A
Recruiting	`NCT04897945` - A Shared Decision Making Intervention for Diabetes Prevention in Women With a History of Gestational Diabetes Mellitus	N/A
Not yet recruiting	`NCT04442451` - Mechanisms of Fatigability With Diabetes	N/A
Not yet recruiting	`NCT05925933` - High Protein Diet on Transcriptomic, Metabolomics, Hepatic and Pancreatic Fat Anatomy and Physiology in Asian Indians With Pre-diabetes	N/A
Active, not recruiting	`NCT05654051` - The SLIM LIVER Study	Phase 2
Completed	`NCT02919397` - Motivational Instant Messaging and E-diabetes Prevention Programme for High Risk of Type 2 Diabetes	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.